Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SB 7505

Known as: SB-7505 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
This study compares the effects of digoxin, placebo and ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyl… Expand
Is this relevant?
1986
1986
The pharmacological activity of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine, was compared with that of… Expand
Is this relevant?
1986
1986
Ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyldopamine, was investigated at doses ranging from 1.09 to… Expand
Is this relevant?
1986
1986
The aim of the present investigation was to evaluate the acute hemodynamic effects of a single oral dose of 200 mg ibopamine (SB… Expand
Is this relevant?
1986
1986
The effects of ibopamine (SB-7505, Ib), a new orally active 3,4-diisobutyryl ester of N-methyldopamine, were studied in 8… Expand
Is this relevant?
1986
1986
The effects of a new orally effective dopamine-like derivative, ibopamine (SB-7505), the 3,4-diisobutyryl ester of N… Expand
Is this relevant?
1986
1986
In order to describe kinetics after single administration and to test dose independence in the therapeutic dose range, ibopamine… Expand
Is this relevant?
1986
1986
A multicenter double-blind placebo-controlled investigation was carried out in 42 patients with severe congestive heart failure… Expand
Is this relevant?
1986
1986
The hemodynamic effects of ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyldopamine, were studied in 12… Expand
Is this relevant?
1986
1986
The present paper reports a study of the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine (epinine… Expand
Is this relevant?